"10.1371_journal.pone.0027009","plos one","2011-11-04T00:00:00Z","Ahmed E Enayetallah; Daniel Ziemek; Michael T Leininger; Ranjit Randhawa; Jianxin Yang; Tara B Manion; Dawn E Mather; William J Zavadoski; Max Kuhn; Judith L Treadway; Shelly Ann G des Etages; E Michael Gibbs; Nigel Greene; Claire M Steppan","Compound Safety Prediction Group, Pfizer Inc., Groton, Connecticut, United States of America; Computational Sciences Center of Emphasis, Pfizer Inc., Cambridge, Massachusetts, United States of America; Cardiovascular, Metabolic and Endocrine Diseases Research Unit, Pfizer Inc., Groton, Connecticut, United States of America","Conceived and designed the experiments: SAdE EMG CS. Performed the experiments: ML JY TM DM WZ. Analyzed the data: AE DZ ML JY MK CS. Contributed reagents/materials/analysis tools: AE DZ RR MK NG. Wrote the paper: AE DZ ML CS. Designed the experiments: DM JT.","The authors have read the journal's policy and have the following conflicts: The work has been funded by Pfizer Inc. as part of DGAT1 therapeutic targeting program and the authors are/were paid employee of the funder, Pfizer Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.",NA,NA,NA,"2011","11","Ahmed E Enayetallah","AEE",14,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE
